Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
Andes develops an integrated microbial technology to help accelerate crop growth.
General Sense is a sensory intelligence company that provides analytics, AI integration, and detection solutions for biological olfaction.
Hi Fidelity Genetics is a start up based in Durham, NC.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.
Cypris Materials is a developer of color for the paints, inks, and coatings sectors.
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
MacroCycle Technologies is a cleantech company that develops sustainable and zero-carbon plastic upcycling solutions.
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
PHNX Materials is a manufacturing company that specializes in turning waste into essential materials and reduce carbon emissions.
Reverb Therapeutics engages in the development of treatments for cancer and other diseases.
Rarebird is a coffee company featuring Arabica coffee beans that deliver improved mental wellness outcomes.
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.
Canaery is builds a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds.
Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.
KdT Ventures has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
KdT Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 35 different industry categories.
Among tracked funding rounds, Parthenon Therapeutics received $65.0M in a Series A round. KdT Ventures's total known invested capital is $718.5M.
KdT Ventures's average investment size is $18.0M across its portfolio of 57 companies.
Recent KdT Ventures portfolio additions include SURGE Therapeutics, Andes, General Sense, Hi Fidelity Genetics, Parthenon Therapeutics. These companies were founded in 2020 or later.